Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease in Infants: Recommendations of

This report describes the Advisory Committee on Immunization Practices recommendation for the seasonal administration of a single dose of RSV vaccine during weeks 32 through 36 of pregnancy to help prevent severe RSV illness in infants younger than 6 months.